JelloX Biotech Inc.
Update：2026/08/06
Industries
Main Industry
Biotechnology
Main Product/Service
JelloX has launched the first product “JX ACE 3D Pathology Imaging Service” to provide customers high resolution pathology images. Special advantages including high accuracy, convenience and efficiency make it a rapid and economic commercialized 3D pathol
Founded Year
2018
Unified Business No.
54958394
Status
Active
Number of Employees
0
Total Paid-in
Capital
49,426,680 (NT$)
Location of Company
Taiwan
, Hsinchu County
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
JelloX Biotech Inc. is a university startup by research team from National Tsing Hua University. JelloX owns exclusive in-license and invention patents to develop innovative digital imaging technology and AI analysis platform for next generation pathology with 3D digital pathology image and tissue feature-based diagnosis. We aim at creation of the world first 3D digital pathology solution in support of precision cancer diagnosis, optimize patient treatment outcome, and matching right patients with right drugs at right time. Our slogan is “Reimaging Pathology at New Horizon”
